(
out of
110
reviews
)
Specialties
Board Certification
|
American Board of Psychiatry & Neurology (Neurology)
National Board of Medical Examiners
|
Patient Rating
Patients consistently praise Dr. Rose as a knowledgeable, compassionate MS specialist who listens carefully, explains complex information in plain language, and spends unhurried time addressing concerns. Many highlight his thoroughness, practical recommendations, help navigating medications (including insurance advocacy), and overall accessibility. A subset of comments note issues with scheduling and follow-up communication, occasional variability in engagement, discomfort with trainees in the exam room, and access or cost barriers related to insurance and travel.
Generated via Patient Reviews
5.0
/5
( out of
110 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Neurology
-Professor |
|---|---|
| Board Certification |
American Board of Psychiatry & Neurology (Neurology)
National Board of Medical Examiners
|
Education history
| Undergraduate | Biology (September 1969 to June 1971) - Johns Hopkins University | B.A. |
|---|---|---|
| Professional Medical | Medicine (September 1971 to June 1975) - University of Maryland | M.D. |
| Internship | Medicine (July 1975 to June 1976) - Maryland General Hospital | Intern |
| Residency | Neurology (July 1976 to June 1979) - University of Maryland | Resident |
| Chief Resident | Neurology (July 1978 to June 1978) - University of Maryland | Chief Resident |
| Fellowship | Neurology (July 1979 to June 1980) - National Institute of Health | Fellow |
| Fellowship | Neuroimmunology (July 1981 to June 1985) - National Institute of Health | Fellow |
Selected Publications
Journal Article
- Jacques K, Race J, Goyne C, Fair A, Schuette A, Yang JH, Caillier S, Aaen GS, Abrams A, Benson L, Casper TC, Chitnis T, Gorman MP, Lotze T, Krupp L, Mar S, Ness J, Rensel M, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Wheeler Y, Oksenberg J, Lin J, Waubant E, Graves J (2026). Telomere length as a marker of biological age in paediatric multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry,
- Dong S, Zhang T, Zhai Y, Naatz LC, Carlson NG, Rose JW, Evavold B, Chen (2025). 3-in-one (PD-1)CAR Tregs: A bioengineered cellular therapy for target engagement, activation, and immunosuppression with reparative potential. iScience, 28(11), 113677.
- Schoeps VA, Bhargava P, Virupakshaiah A, Ladakis DC, Moseley C, Chong J, Aaen G, Graves JS, Benson L, Gorman MP, Rensel M, Abrams A, Mar S, Lotze TE, Chitnis T, Waldman A, Krupp L, Rodriguez M, Tillema JM, Rose J, Schreiner T, Qureshi F, Peterson S, Barcellos LF, Casper TC, Newman J, Borkowski K, Waubant E, US Network of Pediatric MS Center (2025). Distinct plasma lipids predict axonal injury and multiple sclerosis activity. Journal of neurology, neurosurgery, and psychiatry, 96(2), 150-157.
- Goyne C, Fair AE, Yilmaz D, Race J, Schuette A, Caillier SJ, Aaen GS, Abrams AW, Benson LA, Casper TC, Chitnis T, Gorman MP, Lotze TE, Krupp LB, Mar SS, Ness JM, Rensel M, Rodriguez M, Rose JW, Schreiner TL, Tillema JM, Waldman AT, Wheeler YS, Barcellos LF, Waubant E, Graves JS, as the US Network of Pediatric MS Center (2025). Epigenetic Aging in Pediatric-Onset Multiple Sclerosis. Neurology, 104(12), e213673.
- Chang G, Sebastian P, Virupakshaiah A, Schoeps VA, Cherbuin N, Casper TC, Gorman MP, Benson LA, Chitnis T, Rensel M, Abrams AW, Lotze T, Mar SS, Schreiner TL, Wheeler YS, Rose JW, Graves J, Krupp LB, Waldman AT, Lucas R, Waubant E, as the US Network of Pediatric Multiple Sclerosis Center (2025). Association Between Sun Exposure and Risk of Relapse in Pediatric-Onset Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation, 12(2), e200375.
- O'Neill KA, Charvet L, Waltz M, George A, Benson LA, Gorman MP, Mar SS, Ness JM, Schreiner T, Waubant E, Weinstock-Guttman B, Wheeler YS, Abrams AW, Chitnis T, Rodriguez M, Rose JW, Tillema JM, Virupakshaiah A, Casper TC, Krupp LB, US Network of Pediatric MS Center (2025). Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years. Neurology, 105(8), e214142.
- Krysko KM, Waltz M, Chitnis T, Weinstock-Guttman B, Aaen GS, Belman A, Benson LA, Gorman MP, Lotze TE, Mar SS, Moodley M, Ness JM, Rensel M, Rodriguez M, Rose JW, Edwards AR, Schreiner TL, Wheeler YS, Barney BJ, Waubant E, Casper TC, Graves JS, as the US Network of Pediatric MS Center (2025). Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis. Neurology, 104(4), e210213.
- Yilmaz D, Adams C, Horton MK, Graves JS, Francisco C, Edwards A, Quach H, Quach D, Aaen G, Lotze T, Mar S, Ness J, Wheeler Y, Gorman MP, Benson L, Weinstock-Guttman B, Waldman A, Schreiner T, Tillema JM, Chitnis T, Rose J, Casper TC, Rensel M, Waubant E, Barcellos LF, Network of Pediatric Multiple Sclerosis Center (2025). Allele-specific vitamin D receptor binding is associated with pediatric-onset multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical, 11(2), 20552173251335625.
- Yang JH, Race J, Sumowski P, Jacques K, Fardad S, Fair A, Hazlett A, Lin J, Yilmaz D, Aaen G, Abrams A, Benson L, Casper TC, Chitnis T, Gorman M, Lotze T, Krupp L, Mar S, Ness J, Rensel M, Rose J, Schreiner T, Tillema JM, Waldman A, Wheeler Y, Barcellos LF, Waubant E, Graves J (2025). Epigenetic age and telomere length correlations in pediatric-onset multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 31(14), 1641-1650.
- Wright MA, Barney BJ, Peterson S, Waltz M, Rose J, Rensel M, Abrams A, Waubant E, Wheeler Y, Rodriguez M, Tillema JM, Krupp L, Gorman M, Benson L, Lotze T, Shukla N, Mar S, Chitnis T, Schreiner T, Vignos M, Casper T (2025). Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry. Journal of child neurology, 41(4), 8830738251367460.
- MacRae R, Race J, Schuette A, Waltz M, Casper TC, Rose J, Abrams A, Rensel M, Waubant E, Virupakshaiah A, Schoeps V, O'Neill K, Ness J, Wheeler Y, Shukla N, Mar S, Rodriguez M, Chitnis T, Gorman M, Benson (2025). Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple sclerosis and related disorders, 97, 106345.
- Abrams AW, Waltz M, Casper TC, Aaen G, Benson LA, Bernfeld EM, Charvet LE, Chitnis T, Francisco C, Gorman MP, Graves JS, Krupp L, O'Neill K, Lotze TE, Mar S, Ness J, Rensel M, Rodriguez M, Rose J, Rutatangwa A, Schreiner T, Shukla N, Tillema JM, Weinstock-Guttman B, Wheeler Y, Waubant E, Krysko KM, US Network of Pediatric MS Center (2025). Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis. Annals of neurology, 99(3), 715-729.
- Mowry EM, Qian P, Meador W, Lynch S, Narayan R, Borazanci A, Robertson D, Qureshi S, Graves J, Silversteen J, Esch M, Tornes L, Riley C, Kaisey M, Sicotte N, Pawate S, Gyang T, Rempe T, Obeidat AZ, Ganesh G, Ryerson LZ, Smith T, Rose J, Carass A, Chalayon O, Kruse-Hoyer M, Salami M, Liu A, Dewey B, Chen JM, Ogburn E, Koch C, Prince J, Cassard SD, Newsome SD, TREAT-MS Trial Tea (2025). The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participants. Contemporary clinical trials, 159, 108117.
- Wong KH, Zeng E, Smith TL, King JB, Marini E, Sorenson A, Hwang H, Stein C, Francis T, Rose JW, Reddy VK, de Havenon AH, Clardy S (2025). Medicare Part D Use and Costs for Immune-Mediated Neurologic Therapies. JAMA network open, 8(10), e2538277.
- Hoshina Y, Liu S, Wright MA, Delic A, Wong KH, Kadish R, Galli J, Rose JW, Greenlee JE, Soldán MMP, Klein J, Peterson LK, Smith TL, Clardy S (2025). Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD. Journal of neuroimmunology, 407, 578709.
- Schoeps VA, Zhou X, Horton MK, Zhu F, McCauley KE, Nasr Z, Virupakshaiah A, Gorman MP, Benson LA, Weinstock-Guttman B, Waldman A, Banwell BL, Bar-Or A, Marrie RA, van Domselaar G, O'Mahony J, Mirza AI, Bernstein CN, Yeh EA, Casper TC, Lynch SV, Tremlett H, Baranzini S, Waubant (2024). US Network of Pediatric MS Centers. Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset. Ann Clin Transl Neurol. 2024 Jan;11(1):169-184. doi: 10.1002/acn3.51944. Epub 2023 Nov 13.PMID: 37955284,
- Gambrah-Lyles C, Varun Kannan 2, Tim Lotze 2, Aaron Abrams 3, Teri Schreiner 4, Moses Rodriguez 5, T Charles Casper 6, John W Rose 7, Mark P Gorman 8, Tanuja Chitnis 9, Sara Loud 10, Yolanda Wheeler 11, Soe Mar 12; US Network of Pediatric MS Center (2024). Assessing the Needs and perceptions in research participation pediatric onset multiple sclerosis; a multi-stakeholder survey. Pediatr Neurol. 2024 Feb:151:115 120. doi:10.1016/j.pediatrneurol.2023.11.019.Epub 2023 Dec 4. PMID: 38154238,
- Nasr Z, Virupakshaiah A, Schoeps VA, Cherbuin N, Casper TC, Waltz M, Hart J, Rodriguez M, Gorman MP, Benson LA, Chitnis T, Rensel M, Abrams A, Krupp L, Waldman AT, Lotze T, Aaen GS, Mar S, Schreiner T, Wheeler Y, Rose J, Shukla NM, Barcellos LF, Lucas R, Waubant (2024). Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. Multiple sclerosis and related disorders, 82, 105351.
- Jensen SKG, Camposano S, Berens A, Waltz M, Krupp LB, Charvet L, Belman AL, Aaen GS, Benson LA, Candee M, Casper TC, Chitnis T, Graves J, Wheeler YS, Kahn I, Lotze TE, Mar SS, Rensel M, Rodriguez M, Rose JW, Rubin JP, Tillema JM, Waldman AT, Weinstock-Guttman B, Barcellos LF, Waubant E, Gorman MP, US Network of Pediatric Multiple Sclerosis Center (2024). Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study. Neurology(R) neuroimmunology & neuroinflammation, 11(5), e200282.
- Wilson E, Meeks HD, Barney BJ, Waltz M, Canenguez K, Casper TC, Rose JW, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Rensel M, Abrams AW, Krupp LB, Lotze TE, Fisher KS, Shukla NM, Schreiner TL, Mar SS, Waubant E, Virupakshaiah A, Wheeler YS, Ness JM, Benson LA, as the United States Network of Pediatric Multiple Sclerosis Center (2024). Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States. Neurology, 103(11), e209991.
- Virupakshaiah A, Schoeps VA, Race J, Waltz M, Sharayah S, Nasr Z, Moseley CE, Zamvil SS, Gaudioso C, Schuette A, Casper TC, Rose J, Flanagan EP, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Graves JS, Benson LA, Rensel M, Abrams A, Krupp L, Lotze TE, Aaen G, Wheeler Y, Schreiner T, Waldman A, Chong J, Mar S, Waubant (2024). Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. Journal of neurology, neurosurgery, and psychiatry, 96(1), 68-75.
- Nasr Z, Casper TC, Waltz M, Virupakshaiah A, Lotze T, Shukla N, Chitnis T, Gorman M, Benson LA, Rodriguez M, Tillema JM, Krupp L, Schreiner T, Mar S, Rensel M, Rose J, Liu C, Guye S, Manlius C, Waubant E, U.S. Network of Pediatric Multiple Sclerosis Center (2024). Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. Multiple sclerosis and related disorders, 87, 105647.
- Gholizadeh S, Exuzides A, Sinnott J, Palmer C, Waltz M, Rose JW, Jolley AM, Behne JM, Behne MK, Blaschke TF, Smith TJ, Lewis KE, Cook LJ, Yeaman MR, Guthy-Jackson Charitable Foundation CIRCLES Study Grou (2024). Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort. Scientific reports, 14(1), 26150.
- Hoshina Y, Abbatemarco JR, Rodenbeck SJ, Poon JT, Liu SC, Paz Soldan MM, Greenlee JE, Rose JW, Peterson LK, Johnson L, Delic A, Smith TL, Clardy S (2024). Matched oligoclonal bands: Diagnostic utility and clinical characteristics. Annals of clinical and translational neurology, 11(11), 2846-2854.
- Schreiner T, Wilson-Murphy M, Mendelt-Tillema J, Waltz M, Codden R, Benson L, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Roalstad S, Rodriguez M, Rose J, Shukla N, Waubant E, Wheeler Y, Casper TC, Chitnis T (2023). Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Mult Scler. 2023 Apr;29(4-5):576-584. doi: 10.1177/13524585231151948. Epub 2023 Mar 23.PMID: 36960480,
- Malani Shukla N, Casper TC, Ness J, Wheeler Y, Chitnis T, Lotze T, Gorman M, Benson L, Weinstock-Guttmann B, Aaen G, Rodriguez M, Tillema JM, Krupp L, Schreiner T, Mar S, Goyal M, Rensel M, Abrams A, Rose J, Waltz M, Liu T, Manlius C, Waubant (2023). U.S. Network of Pediatric Multiple Sclerosis Centers. Pediatr Neurol. 2023 Aug;145:125-131. doi: 10.1016/j.pediatrneurol.2023.04.020. Epub 2023 Apr 28.PMID: 37348193,
- Horton MK, Shim JE, Wallace A, Graves JS, Aaen G, Greenberg B, Mar S, Wheeler Y, Weinstock-Guttman B, Waldman A, Schreiner T, Rodriguez M, Tillema JM, Chitnis T, Krupp L, Casper TC, Rensel M, Hart J, Quach HL, Quach DL, Schaefer C, Waubant E, Barcellos L (2023). Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis. Mult Scler. 2023 Apr;29(4-5):505-511. doi: 10.1177/13524585221150736. Epub 2023 Feb 8.PMID: 36755464,
- Pizzolato Umeton R, Waltz M, Aaen GS, Benson L, Gorman M, Goyal M, Graves JS, Harris Y, Krupp L, Lotze TE, Shukla NM, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, Roalstad S, Rodriguez M, Rose J, Waubant E, Weinstock-Guttman B, Casper C, Chitnis T, US Network of Pediatric MS Center (2023). Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology, 100(9), e985-e994.
- Gholizadeh S, Exuzides A, Lewis KE, Palmer C, Waltz M, Rose JW, Jolley AM, Behne JM, Behne MK, Blaschke TF, Smith TJ, Sinnott J, Cook LJ, Yeaman MR, Guthy-Jackson Charitable Foundation CIRCLES Study Grou (2023). Clinical and epidemiological correlates of treatment change in patients with NMOSD: insights from the CIRCLES cohort. Journal of neurology, 270(4), 2048-2058.
- Hoshina Y, Wong KH, Galli J, Bacharach R, Klein J, Lebiedz-Odrobina D, Rose JW, Trump B, Hull C, Greenlee JE, Clardy S (2023). Neurologic involvement in seronegative primary Sjögren's syndrome with positive minor salivary gland biopsy: a single-center experience. Frontiers in neurology, 14, 1174116.
- Nasr Z, Schoeps VA, Ziaei A, Virupakshaiah A, Adams C, Casper TC, Waltz M, Rose J, Rodriguez M, Tillema JM, Chitnis T, Graves JS, Benson L, Rensel M, Krupp L, Waldman AT, Weinstock-Guttman B, Lotze T, Greenberg B, Aaen G, Mar S, Schreiner T, Hart J, Simpson-Yap S, Mesaros C, Barcellos LF, Waubant (2023). Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. Journal of neurology, neurosurgery, and psychiatry, 94(7), 518-525.
- Ziaei A, Lavery AM, Shao XM, Adams C, Casper TC, Rose J, Candee M, Weinstock-Guttman B, Aaen G, Harris Y, Graves J, Benson L, Gorman M, Rensel M, Mar S, Lotze T, Greenberg B, Chitnis T, Hart J, Waldman AT, Barcellos LF, Waubant (2022). Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. Multiple sclerosis (Houndmills, Basingstoke, England), 28(9), 13524585211069926.
- Villani LA, Stulberg EL, Abbatemarco JR, Davidson CJ, Kadish R, Renner DR, Soldan MMP, Rose JW, Clardy SL, Greenlee J (2021). Biopsy-proven PML in an HIV-negative patient with discoid lupus: Failure to detect JC virus in CSF. Clinical neurology and neurosurgery, 209, 106843.
- Burt RK, Balabanov R, Han X, Quigley K, Arnautovic I, Helenowski I, Rose J, Siddique (2021). Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial. Neurology, 96(6), e817-e830.
- Jeong K, Shah LM, Lee YJ, Thapa B, Sapkota N, Bisson E, Carlson NG, Jeong EK, Rose J (2021). High-b diffusivity of MS lesions in cervical spinal cord using ultrahigh-b DWI (UHb-DWI). NeuroImage. Clinical, 30, 102610.
- Abbatemarco JR, Galli JR, Sweeney ML, Carlson NG, Samara VC, Davis H, Rodenbeck S, Wong KH, Paz Soldan MM, Greenlee JE, Rose JW, Delic A, Clardy S (2021). Modern Look at Transverse Myelitis and Inflammatory Myelopathy: Epidemiology of the National Veterans Health Administration Population. Neurology(R) neuroimmunology & neuroinflammation, 8(6),
- Greenberg BM, Casper TC, Mar SS, Ness JM, Plumb P, Liang S, Goyal M, Weinstock-Guttman B, Rodriguez M, Aaen GS, Belman A, Barcellos LF, Rose JW, Gorman MP, Benson LA, Candee M, Chitnis T, Harris YC, Kahn IL, Roalstad S, Hart J, Lotze TE, Rensel M, Rubin JP, Schreiner TL, Tillema JM, Waldman AT, Krupp L, Graves J, Drake K, Waubant (2021). Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation, 8(5),
- Williams JP, Abbatemarco JR, Galli JJ, Rodenbeck SJ, Peterson LK, Haven TR, Street M, Rose JW, Greenlee JE, Soldan MMP, Clardy S (2021). Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay. Multiple sclerosis international, 2021, 8692328.
- Mandel LA, O'Donnell E, Canenguez K, Castro-Mendoza PB, Lotze T, Waubant E, Weinstock-Guttmann B, Chitnis T (2021). Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis. Enhancing Equity.,
- Mandel LA, O'Donnell E, Canenguez K, Castro-Mendoza PB, Lotze T, Waubant E, Weinstock-Guttmann B, Chitnis (2021). Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity. Journal of patient experience, 8, 23743735211039319.
- Gaudioso C, Oo S, Mar S, Hendricks-Ferguson VL, Newland P, Varni J (2021). PedsQL Multiple Sclerosis Module Domain and Item Development: Qualitative Methods. Journal of child neurology, 36(10), 901-910.
- Santoro JD, Kerr LM, Codden R, Casper TC, Greenberg BM, Waubant E, Kong SW, Mandl KD, Gorman M (2021). Increased Prevalence of Familial Autoimmune Disease in Children With Opsoclonus-Myoclonus Syndrome. Neurology(R) neuroimmunology & neuroinflammation, 8(6),
- Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, Rutatangwa A, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Goyal MS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waltz M, Casper TC, Waubant E, US Network of Pediatric MS Centers (2020). Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Annals of neurology, 88(1), 42-55.
- Chitnis T, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Roalstad S, Rose J, Weiner HL, Casper TC, Rodriguez M, US Network of Paediatric Multiple Sclerosis Centers (2020). Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain, 143(9), 2733-2741.
- Santoro JD, Waltz M, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rensel M, Rodriguez M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Hurtubise BF, Roalstad S, Rose J, Casper TC, Chitnis T, US Network of Pediatric MS Centers (2020). Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology, 95(13), e1844-e1853.
- Chan A, Rose J, Alvarez E, Bar-Or A, Butzkueven H, Fox RJ, Gold R, Gudesblatt M, Haartsen J, Spelman T, Wright K, Ferraro D, Sola P, Hodgkinson S, Kalincik T, Lechner-Scott J, McGuigan C, Spach K, Chen C, Fam S, Wu F, Miller (2020). Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS. Neurology. Clinical practice, 10(6), 510-519.
- Lord J, Paz Soldan MM, Galli J, Salzman KL, Kresser J, Bacharach R, DeWitt LD, Klein J, Rose J, Greenlee J, Clardy S (2020). Neurosarcoidosis: Longitudinal experience in a single-center, academic healthcare system. Neurology(R) neuroimmunology & neuroinflammation, 7(4),
- Thapa B, Sapkota N, Lee Y, Jeong K, Rose J, Shah LM, Bisson E, Jeong E (2019). Ultra-high-b radial diffusion-weighted imaging (UHb-rDWI) of human cervical spinal cord. Journal of magnetic resonance imaging, 49(1), 204-211.
- Aaen G, Waltz M, Vargas W, Makhani N, Ness J, Harris Y, Casper TC, Benson L, Candee M, Chitnis T, Gorman M, Graves J, Greenberg B, Lotze T, Mar S, Tillema JM, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Belman A, Waubant E, Krupp (2019). Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. Journal of child neurology, 34(3), 148-152.
- Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski I (2019). Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial. JAMA, 321(2), 165-174.
- Wallach AI, Waltz M, Casper TC, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze TE, Mar S, Moodley M, Ness JM, Rensel M, Rodriguez M, Rose JW, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Charvet LE, Krupp L (2019). Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. Multiple sclerosis (Houndmills, Basingstoke, England), 26(14), 1938-1947.
- Graves JS, Barcellos LF, Krupp L, Belman A, Shao X, Quach H, Hart J, Chitnis T, Weinstock-Guttman B, Aaen G, Benson L, Gorman M, Greenberg B, Lotze T, Soe M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Casper TC, Waubant (2019). Vitamin D genes influence MS relapses in children. Multiple sclerosis (Houndmills, Basingstoke, England), 26(8), 894-901.
- Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, Krupp L, Gorman M, Benson L, Chitnis T, Mar S, Belman A, Casper TC, Rose J, Moodley M, Rensel M, Rodriguez M, Greenberg B, Kahn L, Rubin J, Schaefer C, Waubant E, Langer-Gould A, Barcellos L (2019). Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS genetics, 15(1), e1007808.
- Rhead B, Shao X, Graves JS, Chitnis T, Waldman AT, Lotze T, Schreiner T, Belman A, Krupp L, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee MS, Gorman M, Benson L, Mar S, Kahn I, Rose J, Casper TC, Quach H, Quach D, Schaefer C, Waubant E, Barcellos LF, US Network of Pediatric MS Centers (2019). miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Annals of clinical and translational neurology, 6(6), 1053-1061.
- Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR, Guthy-Jackson Charitable Foundation International Clinical Consortium (GJCF'ICC) (2019). Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Neurology(R) neuroimmunology & neuroinflammation, 6(5), e583.
- Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BW, Aaen G, Tillema JM, Mar S, Hart J, Ness J, Harris Y, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos LF, Lotze T, Carmichael SL, Roalstad S, Casper CT, Waubant (2018). Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 89(1), 28-33.
- Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, Charles Casper T, Waubant E, US Network of Pediatric MS Centers (2018). Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology, 91(19), e1778-e1787.
- Cohan S, Kappos L, Giovannoni G, Wiendl H, Selmaj K, Havrdová EK, Rose J, Greenberg S, Phillips G, Ma W, Wang P, Lima G, Sabatella (2018). Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE. Multiple sclerosis (Houndmills, Basingstoke, England), 24(14), 1883-1891.
- Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Schaefer C, Barcellos LF, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2018). Genetic risk factors for pediatric-onset multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 24(14), 1825-1834.
- Pakpoor J, Seminatore B, Graves JS, Schreiner T, Waldman AT, Lotze TE, Belman A, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, McDonald JC, Hart J, Ness JM, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Kahn I, Rose J, Carmichael SL, Roalstad S, Waltz M, Casper TC, Waubant E, US Network of Pediatric Multiple Sclerosis Centers (2018). Dietary factors and pediatric multiple sclerosis: A case-control study. Multiple sclerosis (Houndmills, Basingstoke, England), 24(8), 1067-1076.
- Suleiman L, Waubant E, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Gorman M, Goyal M, Greenberg B, Harris Y, Hart J, Kahn I, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Nourbakhsh B, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Casper TC, Waltz M, Graves JS, Network of Pediatric Multiple Sclerosis Centers (2018). Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Multiple sclerosis and related disorders, 22, 103-107.
- Mar S, Liang S, Waltz M, Casper TC, Goyal M, Greenberg B, Weinstock-Guttman B, Rodriguez M, Aaen G, Belman A, Barcellos LF, Rose J, Gorman M, Benson L, Candee M, Chitnis T, Harris Y, Kahn I, Roalsted S, Hart J, Lotze T, Moodley M, Ness J, Rensel M, Rubin J, Schreiner T, Tillema JM, Waldman A, Krupp L, Graves JS, Waubant E, U.S. Network of Pediatric Multiple Sclerosis Centers (2018). Several household chemical exposures are associated with pediatric-onset multiple sclerosis. Annals of clinical and translational neurology, 5(12), 1513-1521.
- Lavery AM, Waubant E, Casper TC, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Charvet L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waldman A (2018). Urban air quality and associations with pediatric multiple sclerosis. Annals of clinical and translational neurology, 5(10), 1146-1153.
- Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, Casper TC, Waldman A, Belman A, Greenberg B, Goyal M, Harris Y, Kahn I, Lotze T, Mar S, Schreiner T, Aaen G, Hart J, Ness J, Rubin J, Tillema JM, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Candee M, Weinstock-Guttman B, Shao X, Barcellos L, James J, Waubant E, US Network of Pediatric MS Centers (2018). Heterogeneity in association of remote herpesvirus infections and pediatric MS. Annals of clinical and translational neurology, 5(10), 1222-1228.
- Katz Sand I, Fabian MT, Telford R, Kraus TA, Chehade M, Masilamani M, Moran T, Farrell C, Ebel S, Cook LJ, Rose J, Lublin F (2018). Open-label, add-on trial of cetirizine for neuromyelitis optica. Neurology(R) neuroimmunology & neuroinflammation, 5(2), e441.
- Bourne T, Waltz M, Casper TC, Kavak K, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Graves J, Greenberg B, Gorman M, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Olsen C, Roalstad S, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Kahn I, Waldman A, Barcellos L, Waubant E, Weinstock-Guttman B, US Network of Pediatric MS Centers (2017). Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population. Journal of the neurological sciences, 375, 371-375.
- Sapkota N, Shi X, Shah LM, Bisson EF, Rose JW, Jeong E (2017). Two-dimensional single-shot diffusion-weighted stimulated EPI with reduced FOV for ultrahigh-b radial diffusion-weighted imaging of spinal cord. Magnetic resonance in medicine, 77(6), 2167-2173.
- Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Bäärnhielm M, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Metayer C, Schaefer C, Barcellos LF, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2017). Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology, 88(17), 1623-1629.
- Baldassari LE, Rose J (2017). Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis. Neurotherapeutics, 14(4), 842-858.
- Rose JW, Giovannoni G, Wiendl H, Gold R, Havrdová E, Kappos L, Selmaj KW, Zhao J, Riester K, Tsao LC, Greenberg S (2017). Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis. Multiple sclerosis and related disorders, 17, 32-40.
- Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waubant E, U.S. Network of Pediatric MS Centers (2017). Examining the contributions of environmental quality to pediatric multiple sclerosis. Multiple sclerosis and related disorders, 18, 164-169.
- Graves JS, Chitnis T, Weinstock-Guttman B, Rubin J, Zelikovitch AS, Nourbakhsh B, Simmons T, Waltz M, Casper TC, Waubant E, Network of Pediatric Multiple Sclerosis Center (2017). Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis. Pediatrics, 139(4),
- Nourbakhsh B, Graves J, Casper TC, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos L, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2016). Dietary salt intake and time to relapse in paediatric multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 87(12), 1350-1353.
- Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, Rodriguez M, Lotze T, Gorman M, Benson L, Belman A, Weinstock-Guttman B, Aaen G, Graves J, Patterson M, Rose JW, Casper T (2016). Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology, 86(3), 245-52.
- Belman AL, Krupp LB, Olsen CS, Rose JW, Aaen G, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze T, Ness J, Rodriguez M, Tillema JM, Waubant E, Weinstock-Guttman B, Casper TC, US Network of Pediatric MS Centers (2016). Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics, 138(1),
- Graves J, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant (2016). The US Network of Pediatric Multiple Sclerosis Centers: Genetic predictors of relapse rate in pediatric MS. Multiple sclerosis (Houndmills, Basingstoke, England), 1-8.
- Sapkota N, Yoon S, Thapa B, Lee Y, Bisson EF, Bowman BM, Miller SC, Shah LM, Rose JW, Jeong E (2016). Characterization of spinal cord white matter by suppressing signal from hindered space. A Monte Carlo simulation and an ex vivo ultrahigh-b diffusion-weighted imaging study. Journal of magnetic resonance (San Diego, Calif., 272, 53-59.
- McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema J, Rodriquez M, Chitnis T, Mar S, Barcellos L, Laraia B, Rose JW, Roalstad S, Simmons T, Casper TC, Waubant (2016). A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Multiple sclerosis and related disorders, 6(Mar 2016), 87-92.
- Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Olsen C, Misra M, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Krupp L, Lotze T, Mar S, Ness J, Rose J, Rubin J, Schreiner T, Tillema J, Waldman A, Rodriguez M, Casper C, Waubant E, U.S. Network of Pediatric MS Centers (2016). Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. Annals of clinical and translational neurology, 3(12), 897-907.
- Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, US Network of Pediatric MS Center (2016). Gut microbiota composition and relapse risk in pediatric MS: A pilot study. Apr 16(363), 153-157.
- Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Spencer CM, Lynch SV, Zamvil SS, Waubant E, US Network of Pediatric MS Center (2016). Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC neurology, 16(1), 182.
- Graves JS, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant E, U.S. Network of Pediatric MS Center (2016). Genetic predictors of relapse rate in pediatric MS. Multiple sclerosis (Houndmills, Basingstoke, England), 22(12), 1528-1535.
- Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris Y, US Network of Pediatric Multiple Sclerosis Centers (2015). The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. Journal of child neurology, 30(10), 1381-7.
- Kappos L, Wiendle H, Selmaj K, Arnold DL, Havrdova E, Boyko A, Kaufman M, Rose JW, Greenberg S, Sweetser M, Riester K, O'Neill G, Elkins (2015). Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis. The New England journal of medicine, 373(15), 1418-28.
- Carlson NG, Bellamkonda S, Schmidt L, Redd J, Huecksteadt T, Weber LM, Davis E, Wood B, Maruyama T, Rose J (2015). The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death. Journal of neuroinflammation, 12, 101.
- Loughran-Fjeldstad AS, Carlson NG, Husebye CD, Cook LJ, Rose J (2015). Retinal nerve fiber layer sector-specific compromise in relapsing and remitting multiple sclerosis. eNeurologicalSci, 1, 30-37.
- Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris (2014). The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. Journal of child neurology, 09/30/2014, 1-7.
- Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, Simmons T, Casper TC, James J, Waubant E, US Network of Pediatric Multiple Sclerosis Centers (2014). Protective environmental factors for neuromyelitis optica. Neurology, 83(21), 1923-9.
- Charvet LE, Cleary RE, Vazquez K, Belman AL, Krupp L (2014). Social cognition in pediatric-onset multiple sclerosis (MS). Multiple sclerosis (Houndmills, Basingstoke, England), 20(11), 1478-84.
- Charvet LE, O'Donnell EH, Belman AL, Chitnis T, Ness JM, et al (2014). Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the "US Pediatric Multiple Sclerosis Network". Multiple sclerosis (Houndmills, Basingstoke, England), 20(11), 1502-10.
- Sheridan JP, Robinson RR, Rose J (2014). Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis. Expert review of clinical pharmacology, 7(1), 9-19.
- Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda (2013). Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. The American journal of pathology, 183(5), 1390-1396.
- Seo HS, Kim SE, Rose JW, Hadley JR, Parker DL, Jeong E (2013). Diffusion tensor imaging of extraocular muscle using two-dimensional single-shot interleaved multiple inner volume imaging diffusion-weighted EPI at 3 tesla. Journal of magnetic resonance imaging, 38(5), 1162-1168.
- Martins TB, Rose JW, Gardiner GL, Kusukawa N, Husebye D, Hill H (2013). Cell-based reporter gene assay for therapy-induced neutralizing antibodies to interferon-beta in multiple sclerosis. Journal of interferon research, 33(2), 52-7.
- Carlson NG, Rose J (2013). Vitamin D as a clinical biomarker in multiple sclerosis. Expert opinion on medical diagnostics, 7(3), 231-42.
- Yonnet GJ, Fjeldstad AS, Carlson NG, Rose J (2013). Advances in the management of neurogenic detrusor overactivity in multiple sclerosis. International journal of MS care, 15(2), 66-72.
- Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, Pelletier D, Erickson B, Bergsland N, Zivadinov R, U.S. Network of Pediatric MS Centers of Excellenc (2013). Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. BMC neurology, 13, 173.
- Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, O'Donnell E, Parrish J, Preston T, Zaccariello M, Belman A, Chitnis T, Gorman M, Ness J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Yeh A, Krupp LB, Network of Pediatric MS Centers of Excellenc (2013). Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. Journal of child neurology, 28(1), 102-7.
- Langer HF, Choi EY, Zhou H, Schleicher R, Chung KJ, Tang Z, Gobel K, Bdeir K, Chatzigeorgiou A, Wong C, Bhatia S. Kruhlak MJ, Rose JW, Burns JB, Hill KE, Qu H, Zhang Y, Lehrmann E, Becker KG, Wang Y, Simon DI, Nieswandt B., Lambris JD, Li X, Meuth SG, Kubes P, Chavakis T (2012). Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circulation research, 110(9), 1202-10.
- Fjeldstad AS, Carlson NG, Rose J (2012). Optical coherence tomography as a biomarker in multiple sclerosis. Expert opinion on medical diagnostics, 6(6), 593-604.
- Merrill RP, Hadley JR, Minalga E, Kholmovski EG, Vijayakumar S, Kim SE, Quigley EP, Parker DL, Rose J (2012). A 28-channel coil array for improved imaging of the optic nerve. Science translational medicine, 41B(3), 73-84.
- Rose J (2012). Anti-CD25 immunotherapy: regulating the regulators. Science translational medicine, 4(145), 145fs25.
- Martins TB, Rose JW, Jaskowski TD, Wilson AR, Husebye D, Seraj HS, Hill HR (2011). Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay. American journal of clinical pathology, 136(5), 696-704.
- Zollinger LV, Kim TH, Hill K, Jeong EK, Rose J (2011). Using diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis. Journal of magnetic resonance imaging, 33(3), 557-64.
- Waldman AT, Gorman MP, Rensel MR, Austin Te, Hertz DP, et a (2011). Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. Journal of child neurology, 26(6), 675-82.
- Fjeldstad AS, McDaniel J, Witman MA, Ives SJ, Zhao J, Rose JW, Hannon J, Wray DW, Richardson R (2011). Vascular function and multiple sclerosis. Journal of neurology, 258(11), 2036-42.
- Minalga E, Rose JW, Choi SE, Jeong EK, Kholmovski E, et a (2011). A 20-channel coil for improved magnetic resonance imaging of the optic nerve. Concepts in magnetic resonance. Part B, Magnetic resonance engineering, 25(39B(1)), 26-36.
- Rose JW, Carlson N (2011). Clinical biomarkers in multiple sclerosis. Expert opinion on medical diagnostics, 5(3), 213-26.
- Waldman AT, Gorman MP, Rensel MR, Austin TE, Hertz DP, Kuntz NL, Network of Pediatric Multiple Sclerosis Centers of Excellence of National Multiple Sclerosis Societ (2011). Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. Journal of child neurology, 26(6), 675-82.
- Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, Rodriguez M, Rinker JR 2nd, Weinstock-Guttman B, National Network of Pediatric MS Centers of Excellenc (2011). Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Archives of neurology, 68(4), 437-44.
- Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, Oksenberg JR, James JA, US Pediatric MS Networ (2011). Common viruses associated with lower pediatric multiple sclerosis risk. Neurology, 76(23), 1989-95.
- Kim TH, Zollinger L, Shi XF, Kim SE, Rose J, Patel AA, Jeong E (2010). Quantification of diffusivities of the human cervical spinal cord using a 2D single-shot interleaved multisection inner volume diffusion-weighted echo-planar imaging technique. AJNR. American journal of neuroradiology, 31(4), 682-7.
- Ford C, Goodman AD, Johnson K, Kachuck N, Lindsey JW, Lisak R, Luzzio C, Myers L, Panitch H, Preiningerova J, Pruitt A, Rose J, Rus H, Wolinski (2010). Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. Multiple sclerosis (Houndmills, Basingstoke, England), Mar(3), 342-50.
- Wynn D, Kaufman M, Montalban X, Vollmer T, Simon J, Elkins J, O'Neill G, Neyer L, Sheridan J, Wang C, Fong A, Rose JW, CHOICE investigators (2010). Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. The Lancet. Neurology, 9(4), 381-90.
- Carlson NG, Rojas MA, Redd JW, Tang P, Wood B, Hill KE, Rose J (2010). Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death. Journal of neuroinflammation, 7, 25.
- Chabas D, Ness J, Belman A, Yeh EA, Kuntz N, Gorman MP, Strober JB, De Kouchkovsky I, McCulloch C, Chitnis T, Rodriguez M, Weinstock-Guttman B, Krupp LB, Waubant E, US Network of Pediatric MS Centers of Excellenc (2010). Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology, 74(5), 399-405.
- Kim T, Zollinger L, Shu X, Rose JW, Jeong (2009). Diffusion tensor imaging of ex vivo cervical spinal cord specimens: the immediate and long term effects of fixation on diffusivity. The Anatomical record, 292, 234-41.
- Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, Hill HR, Fire E, Spector L, Yarden J, Dotan N, Rose J (2009). Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. Journal of neuroimmunology, 217(1-2), 95-101.
- Wolinski JS, Sochat T, Weiss S, Ladkani D: PROMiSe Trial Study Group (J Rose site PI (2009). Glatiramer acetate treatment in PPMS: why males appear to respond favorably. Journal of the neurological sciences, 15, 286-928.
- Mehta LR, Rose J (2009). Recurrent granuloma annulare during treatment with daclizumab. Multiple sclerosis (Houndmills, Basingstoke, England), 15(4), 527-8.
- Rose JW, Foley JF, Carlson N (2009). Monoclonal antibody treatments for multiple sclerosis. Current treatment options in neurology, 11(3), 211-20.
- Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose JW, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Volterelli JC, Burns W (2009). Autologous non-myeloablative heamtopoetic stem cell transplantation for relapsing and remitting multiple sclerosis. The Lancet. Neurology, 8, 244-53.
- Carlson NG, Rojas MA, Black JD, Redd JW, Hille J, Hill KE, Rose J (2009). Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor. Journal of neuroinflammation, 6, 5.
- Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee J (2009). Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. Journal of neuroinflammation, 6, 31.
- Rojas MA, Carlson NG, Miller TL, Rose J (2009). Long-term daclizumab therapy in relapsing-remitting multiple sclerosis. Therapeutic advances in neurological disorders, 2(5), 291-7.
- Wolinsky J (2003). The diagnosis of primary progressive multiple sclerosis. Journal of the neurological sciences, 206(2), 145-52.
Review
- Burt RK, Burman J, Greco R, Rose J (2024). Hematopoietic stem cell transplantation for neuromyelitis optica spectrum disorder. Can immune tolerance be reestablished?. Handbook of clinical neurology, 202, 169-197.
- Kuntz NL, Chabas D, Weinstock-Guttman B, Chitnis T, Yeh EA, Krupp L, Ness J, Rodriguez M, Waubant E, Network of US Pediatric Multiple Sclerosis Center (2010). Treatment of multiple sclerosis in children and adolescents. Expert opinion on pharmacotherapy, 11(4), 505-20.
- Yeh EA, Chitnis T, Krupp L, Ness J, Chabas D, Kuntz N, Waubant E, US Network of Pediatric Multiple Sclerosis Centers of Excellenc (2009). Pediatric multiple sclerosis. Nature reviews. Neurology, 5(11), 621-31.
Book Chapter
- Jacobson S, Rose J, Flerlage M, Mingioli E, McFarlin D, McFarland (1986). Measles virus-specific human cytotoxic T cells generated in bulk cultures: Analysis of measles virus antigenic specificity.
Book Review
- Rose J (1984). Neuroimmunology.
Editorial
- Rose J (2009). Multiple sclerosis: evidence of maternal effects and an increasing incidence in women. Neurology, 73(8), 578-9.
- Rose (2009). Multiple Sclerosis: Evidence of Maternal Effects and an Increasing Incidence in Women. Neurology, 73(8), 578-9.
Abstract
- Tremlett H, Fadrosh D, Lynch S, Hart J, Gravas J, Lulu S, Aaen G, Belman A, Benson L, Casper C, Chitnis T, Gorman M, Krupp L, Lotze T, Ness J, Roalstac S, Rodriquez M, Rose JW, Tillema JM, Weinstock-Guttman B, Waubant (2015). Gut Microbiome in Early Pediatric Multiple Sclerosis: A Case-control Study. Neurology, 84(14 Supplement), P4.027.
- McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tilleman JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos L, Rose JW, Roalstad S, Simmons T, Casper TC, Waubant (2015). A Case-control Study of Dietary Salt Intake and Risk of Pediatric Multiple Sclerosis (MS). Washington D.C. Neurology, 84(14 Supplement), S38.003.
- Seminatore B, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos L, Rose JW, Roalstad S, Simmons T, Casper C, Waubant (2015). Fat, Fiber, and Pediatric MS. Neurology, 84(14 Supplement), S38.002.
- Selmaj K, Kappos L, Arnold D, Havrdova E, Boyko A, Kaufman M, Wiendl H, Rose JW, Greenberg S, Riester K, Sweetser M, Elkins (2015). Safety and Tolerability Results from the DECIDE Study: A Phase 3 Active-comparator Study of Daclizumab HYP in Relapsing-remitting Multiple Sclerosis. Neurology, 84(14 Supplement), P7.230.
- Paz Soldan M, Schmidt L, Wood B, Rose JW, Carlson (2015). Prostaglandin F2a Receptor Mediates Oligodendrocyte Precursor Injury/Death: Potential Rose in Multiple Sclerosis. Washington D.C. Neurology, 84(14 Supplement), P5.210.
- Rose JW, Wiendl H, Arnold D, Kappos L, Havrdova E, Selmaj K, Boyko A, Kaufman M, Greenberg S, Sweetser M, Riester K, Elkins (2015). Daclizumab HYP Reduced Brain MRI Lesion Activity Compared with Interferon Beta-1a: Results from the DECIDE Study. Neurology, 84(14 Supplement), P7.252.
- Wang V, Clardy T, Rose JW, Burns J, Carlson N, Greenlee J, Clardy (2015). Neuromyelitis Optica in Veterans. Neurology, 84(14 Supplement), P1.104.
- Kappos L, Selmaj K, Arnold D, Havrdova E, Boyko A, Kaufman M, Wiendl H, Rose JW, Greenberg S, Sweetser M, Riester K, Elkins (2015). Daclizumab HYP Versus Interferon Beta-1a in Relapsing-remitting Multiple Sclerosis: Primary Results of the DECIDE Study. Neurology, 84(14 Suppliment), S4.003.
- Sand IK, Fabian M, Cook L, Chehade M, Masilamani M, Kraus T, Farrell C, Phelps S, Riffle ME, Rose JW, Moran T, Lublin (2015). An Open Label Add-on Trial of Cetirizine for Neuromyelitis Optica. Neurology, 84(14 Supplement), P4.003.
- Wiendl H, Havrdova E, Rose JW, Riester K, Tsao C, Greenberg (2015). Daclizumab HYP Versus Interferon ß-1a Across Patient Demographic and Disease Activity Subgroups in the DECIDE Phase 3 Study. Neurology, 84(14 Supplement), P4.007.
- Nourbakhsh B, Graves J, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema J-M, Hart J, Lee M, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Simmons T, Casper C, Rose JW, Barcellos L, Waubant (2015). Association of dietary salt intake and relapse rate in pediatric multiple sclerosis.
- Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Misra M, Olsen CS, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Lotze T, Ness J, Rodriquez M, Rose JW, Rubin J, Schreiner T, Mendelt-Tillema J, Casper TC, Waubant (2015). Effect of obesity and puberty on risk and age at onset of pediatric MS.
- Aaen GS, Waltz M, Casper T, Ness J, Gorman M, Makahani N, Vargas W, Waubant E, Chitnis T, Lotze T, Graves J, Benson L, Tillema MJ, Rodriguez M, Rose JW, Weinstock-Guttman B, Krupp L, Belman (2015). Acquisition of early developmental milestones and need for special education services in paediatric-onset multiple sclerosis.
- Loughran-Fjeldstad AS, Carlson NG, Cook LJ , Rose J (2015). Longitudinal reduction of total macular volume in relapsing and remitting multiple sclerosis: indicative of ongoing neurodegeneration.
- Wiendl H , Havrdova E, RoseJW, Giovannoni G, Tsao LC, Zhao J, Pan Q, Elkins J, Greenberg S (2015). Daclizumab high-yield process (DAC HYP) vs. intramuscular interferon beta-1a in subgroups predictive of active disease: results from the DECIDE study.
- Arnold DL, Kappos L, Wiendl H, Selmaj K, Havrdova E, Boyko A, Kaufman M, Rose JW, Greenberg S, Amaravadi L, Riestger K, Elkins (2015). Benefits on brain MRI lesion activity with Daclizumab HYP compared with intramuscular interferon beta- 1a are maintained through 144 weeks¿ treatment: results from the DECIDE study.
- Katz Sand I, Fabian M, Cook L, Telford R, Chehade M, Masilamani M, Kraus T, Farrell C, Phelps S, Riffle ME, Rose JW, Moran T, Lublin (2015). An open-label add-on trial of cetirizine for neuromyelitis optica: baseline data and preliminary results.
- Carlson NG, Schmidt L, Redd J, Bellamkonda S, Wood B, Weber LM, Paz Soldan MM, RoseJ (2015). Vulnerability of oligodendrocyte precursor cells to death is modulated by key prostaglandins.
- Kim T, Kim SE, Patel A, Zollinger L, Rose JW, Jeong E (2009). Diffusion tensor imaging of human spinal cords in cervical myelopathy.
- Merrill R, Hadley R, Minalga E, Parker D, Vijayakumar S, Choi SEK, Bell L, Rose J (2009). An improved 28 channel array for optic nerve imaging.
- Carlson N, Rojas M, Redd J, Tang P, Wood B, Hill K, Rose J (2009). Cyclooxygenase-2 expression in oligodendrocytes increases sensitiity to excitotoxic death.
- Tumani H, Brettschneider J, Jakowski T, Abdul S, Husebye D, Seraj H, Hill H, Fire E, Spector L, Dotan N, Rose J (2009). Anti-GAGA4 IgM assay may distinguish primary progressive multiple sclerosis from relapsing remitting multiple sclerosis patients.
- Rose JW, Quigley E, Anderson J, Kim S, Jeong EK, Minalga E, Merrill R, Parker D, Hadley (2009). Imaging of the optic nerve with improved radiofrequency toils for 3T MRI.
- Rose JW, Jaskowski T, Husebye D, Seraj H, Hill H, Carlson (2008). Anti-thyroid antibodies identify a subgroup of multiple sclerosis patients.
- Mehta L, Rose J (2008). Recurrent granuloma annulare occurring during treatment with daclizumab.
- Hadley R, Merrill R, Minalga E, Parker D, Rose J (2008). Improved radio frequency coils for 3T magnetic resonance imaging of the optic nerve.
- Tsunoda I, Carlson N, Rose J (2008). Treatment with a red wine component, resveratrol, in a virus induced model for MS.
- Carlson N, Rojas M, Redd J, Wood B, Hill K, Rose J (2008). A COX-2 inhibitor limits demyelination in a murine model of MS and protects oligodendrocytes from excitotoxic death in culture.
- Jaskowski T, Husebye D, Yarden J, Spector L, Fire E, Dotan N, Hill H, Rose J (2008). Performance of an anti-GAGA4 IgM assay in distinguishing MS patients from control groups in a US cohort: a cross sectional retrospective study.
- Burt R, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Rose JW, Testori A, Muraro P, Storek J and Voltarelli (2008). Autologous non myeloablative hematopoetic stem cell transplantation for relapsing multiple sclerosis.
- Tsunoda I, Rose JW, Carlson (2008). Treatment on an animal model for MS with resveratrol, a red wine component.
- Carlson N, Rojas M, Redd J, Wood B, Hill K, Rose J (2008). The role of COX-2 in experimental oligodendrocytes death and demyelination.
- Carlson N, Rojas M, Black J-D, Redd J, Hill K, Rose J (2008). Neuroprotection by EP1 prostanoid receptor antagonists is modulated by microglia.
Other
- Vikram Bhise a, Michael Waltz b, Charles Casper b, Gregory Aaen c, Leslie Benson d, Tanuja Chitnis e, Mark Gorman f, Manu Goyal g, Yolanda Wheeler h, Timothy Lotze i, Soe Mar j, Mary Rensel k, Aaron Abrams l, Moses Rodriguez m, John Rose n, Teri Schreiner o, Nikita Shukla p, Emmanuelle Waubant q, Bianca Weinstock-Guttman r, Jayne Ness s, Jan Mendelt-Tillema (2023). Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort.
- Jeong KE, Lee SY, Yeom SK, Carlson N, Shah LM, Rose J, Jeong E (2022). Ultrahigh-b diffusion-weighted imaging for quantitative evaluation of myelination in shiverer mouse spinal cord. Magnetic resonance in medicine, 87(1), 179-192.
- Sebastian P, Cherbuin N, Barcellos LF, Roalstad S, Casper C, Hart J, Aaen GS, Krupp L, Benson L, Gorman M, Candee M, Chitnis T, Goyal M, Greenberg B, Mar S, Rodriguez M, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Graves J, Waubant E, Lucas R, US Network of Pediatric Multiple Sclerosis Centers (2022). Association Between Time Spent Outdoors and Risk of Multiple Sclerosis. Neurology, 98(3), e267-e278.
- Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ, (J Rose, S Clardy and MM Paz Soldan in PREVENT Study Group) (2021). Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD. Annals of neurology, 89(6), 1088-1098.
- Horton MK, McCauley K, Fadrosh D, Fujimura K, Graves J, Ness J, Wheeler Y, Gorman MP, Benson LA, Weinstock-Guttman B, Waldman A, Rodriguez M, Tillema JM, Krupp L, Belman A, Mar S, Rensel M, Chitnis T, Casper TC, Rose J, Hart J, Shao X, Tremlett H, Lynch SV, Barcellos LF, Waubant E, U.S. Network of Pediatric MS Centers (2021). Gut microbiome is associated with multiple sclerosis activity in children. Annals of clinical and translational neurology, 8(9), 1867-1883.
Dr. Rose is the best !
He is a very good doctor who is willing to get to the core of the patient problem
A Brilliant Doctor who has assisted me since beginning in 1999 through today.
Did a fantastic job let me know everything he's awesome
Dr. Rose has compassionately and expertly cared for me and my MS for over 24 years, and has blessed me, my life, and my family more than I can ever hope to express.
Dr. rose has taken great care of me for 26 years, since I was diagnosed with MS.
Dr. Rose is a one of a kind doctor. He is caring, compassionate, thorough, explains things in in a way that I understand & never rushes my appointments. I have been seeing him for over 15 years & highly recommend him for patients going through the roller coaster of MS.
Dr Rose is the BEST-knowledgeable & caring
Dr Rose is a caring physician that I genuinely trust.
Dr. Rose is amazing. He is so caring. He listens to me and includes me in my care. I wouldn't see anyone else.
Dr. Rose has been so patient in finding out what my diagnosis is. Thank you so much.
He always makes me feel like I am succeeding.
He's a fantastic doctor who helps me a lot.
Dr rose is a wonderful doctor
He is an amazing, kind,and caring man and doctor. He cares a great deal about not just his patients, but their families too. I am honored to have him as my doctor.
Dr. Rose is an amazing and thorough neurologist and MS specialist. He has taken excellent care of me since 2000, and still remains as interested and attentive as he was 25 years ago. If you have MS or other neurological disorders, I can't recommend anyone as highly as Dr. Rose.
Dr. Rose cares! He remembers my concerns and addresses them in a way I clearly understand. He listens and takes time. Thank you Dr. Rose.
Extremely knowledgeable great interpersonal skills
Very professional and lessens to our concerns
I feel dr rose is very knowledgeable, we're very lucky to have him.
He has been my doctor for over 25 years. I always look forward to seeing him and getting gaining knowledge from him about (MS). I appreciate the way he explained things and shows his concern.
Excellent care.
Dr. Rose is fabulous and very compassionate and understanding.
Dr. Rose is highly recommended for multiple sclerosis diagnosis and treatment!!
Dr Rose is very smart and very willing to help in any way he can and I greatly trust his experience and expertise.
Explains things in a very understandable way. Has compassion. Knows Options and What to look for. And most important LISTENS!
Dr. Rose is an excellent neurologist and MS specialist. I have trusted him for care since being diagnosed in 2000.
He's the BEST!
I've been living with MS for 33 years now and Dr. Rose is the best MS Specialist/neurologist I've ever had. I can't thank Dr. Rose enough for his expert care. He's thorough, compassionate, and always ready to listen. His ability to explain complex medical terms in simple, understandable language is a blessing. I trust him completely with my health care. He has provided me with a wealth of information and guidance on Multiple Sclerosis and other health care issues. Dr. Rose is an amazing doctor who is truly invested in his patients' health. His enthusiasm for his work is apparent. He has provided me with a wealth of information and guidance on Multiple Sclerosis. His explanations are always clear and concise. He takes the time to listen to my concerns and works together with me to come up with the best course of action. Thank you for everything Dr. Rose. You are the best!!!
I liked that he was talking about treatment at my first visit. Obviously a few more tests need to been done but he seems like making me feel better is his #1 priority.
I've been going to Dr Rose for over 20 years!! I love that man! He's such a good doctor!
He's Great! He helped me get a new prescription for Rebif
Dr. Rose is the best!
Dr. Rose and His team are very Knowledgeable innovative patient gentle kind and caring toward his patients!!
Dr. Rose has always treated me with courtesy and respect. I feel that I have received the best care for my diagnosis. There is NO DOUBT that he is the best Dr. in his field. I have been seeing him for almost 30 years, and have been extremely happy with his care!!
Dr. John Rose really took the time to meet with me and my husband to help us understand the results of my recent MRI and helped us understand options for next steps in treatment options. It was a lot to take in, but he helped us understand how to navigate what the possibilities may be. I have complete confidence in him and am so grateful for his help and guidance.
Dr. Rose is a truly amazing doctor. Being an expert on MS, he's exactly the doctor I need.
Dr Rose is an amazing doctor, he is caring and understanding.
I love Dr Rose. Caring and supportive. He includes me in my care and explains everything I have questions about.
Dr. Rose is a wonderful doctor. He takes time and hears all your concerns and addresses everything carefully with care and concern. I'm so grateful to have him as a doctor.
Thank you for truly hearing my concerns, addressing them and including me in the treatment choice (s) by helping me clearly understand options
excellent and very caring doctor. highly recommend!
Dr Rose is the best there is!
Dr. Rose is a wonderful, caring doctor.
Dr. John Rose is A Friendly Knowledgeable patient kind Doctor toward me as a patient. I highly recommend his team to help and serve you.
Dr. Rose is fantastic!
Dr. Rose is terrific
Dr Rose is very thorough and professional. He makes certain that my questions are answered and my needs are met.
Dr Rose always has time to listen
I've been going to dr rose for 24 years. He is the best! I have so much confidence in him and he always acts concerned about all of my health problems.
Incredible doctor and very personable, caring man. I feel very fortunate to have been able to go to him for many years.
patient and informative
Dr. Rose is a very knowledgeable and experienced doctor when it comes to treating Multiple sclerosis, I would recommend him to anybody who needs his help
Dr. Rose is amazing! I have seen him for years. I like that he includes me in coming up with the best treatment plan for my body, which doesn't like meds! I have so much respect for him and his work with MS.
Dr. Rose is the absolute best! I've been seeing him for about 20 years. I don't know what I will do if/when he retires
Dr. Rose is excellent
He is the most kindest, understanding, knowledgeable, Ms doctor.
He treats me like a good friend who cares
He checks all the concern/issues that pertain to my MS and makes changes in my medications.
Dr Rose was very friendly and actually made me feel excited that he would help me find answers to my medical issues.
Dr. Rose incredibly friendly and took the time to discuss and explain my condition. He was incredibly helpful in decision making as well. You can tell he puts patients first.
I trust him completely with my treatment. I wouldn't want anyone else to my specialist for MS
Dr. Rose is very knowledgable and responds to my requests.
Excellent doctor for me for 23 years. So up to date on all things MS.
Dr. Rose is very knowledgeable and caring
Dr. Rose was very pleasant and caring
Fantastic doc that said cares
Very professional, knowledgeable and thorough in his examination. Kind in his demeanor.
Dr Rose is great and I recommend him highly.
He explained to me my options and how ma is affecting me recently
Dr. Rose is the best!!! Always makes me feel important and cared for. He explains things so I understand what's going on with my treatment. He's caring, professional. He has my best interests at heart. Can't do any better than Dr. Rose
MD Rose is AWESOME!!!
Dr Rose is so knowledgeable about MS and how it is manifest in all the systems of the body. I have a lot of other medical problems and he works through each medication and challenges related to the entire body. He listens to each new complaint and after testing and evaluation we come up with a plan that I can try that might improve my quality of life. I am so fortunate to be able to have Dr Rose on my medical team.
I am lucky to have Dr. Rose and have for 20 years now. The best!!!
In my opinion there is no better doctor than Dr. Rose!
I am never rushed and always feel that he is very thorough.
Genius So Thankful he is my physician
Amazing Doctor!!
Kind, knowledgeable, considerate and caring.
Dr. Rose has gone above and beyond to care for me.
He is professional as well as patient and compassionate in his bedside manner . Truly one of the best doctors in M.S care . Always helpful and very knowable.
He is a wonderful doctor. Very caring. Very professional. Takes all the time you need to explain things to you in a way that you understand.
Hes been my doctor for 25 years he is always good to listen to my concerns and respectful to my needs
He is amazing!
Dr. Rose responds to my questions and concerns in a way that is easy for me to understand. He is patient and kind and listens and asks questions based on what I say. He follows through
Dr. Rose has watched over me and my MS for decades
The best Dr. Ever. Exlplains things clear and listens.
Very best Doctor!
Dr. Rose for more than 20 years has been professional, caring, knowledgeable and welling to take the time to explain any concerns or questions we have in every appointment.
Ive been his patient for 16 years and and still feel very blessed to be able to keep seeing him!
Doctor Rose always gives me hope and he is so kind.
Dr. Rose is professional and kind! I hope he never retires.
He goes all of the above in a professional, competent and caring manner
Dr. Rose has always been such a Great Dr. for me... couldn't imagine going thru my MS journey without him.
Visit was helpful and useful.
Outstanding care by Dr Rose. He knows his stuff and explains everything about MS in an easy to understand manner.
He makes me feel comfortable. He knows the issues of MS and he is very knowledgeable.
Dr. Rose has been my provider for almost thirty years. My only fear is that he will retire! He is the BEST in his field to treat my diagnosis!!!
Dr. Rose has been my doctor for 30+ years. He is wonderful, competent, and caring. I would recommend him to anyone.
Dr.Rose is an excellent doctor and he is very thorough and provides the best care. I know I'm always able to rely on him to have answers or a plan.
He is takes his time and closely examines my strengths in my arms, eyes, legs etc He asks questions as well gives me advice/suggestions.
I felt (as I always do) that Dr. Rose is very tuned in with my particular case as if I was his only patient. He is very deliberate with the decisions related to my care. He never pushes me into a decision I am not ready for (need for a wheelchair or safer driving options.)
Ive been seeing Dr Rose for years and hes always provided me with excellent care & concern.
Dr. Rose has been my physician for 20 years and we really know how knowledgeable he is.
As I said Dr Rose has been my doctor for 27 years
I love Dr Rose. I always look forward to our visits. He has lots of helpful suggestions and knowledge that I value and I trust him. Glad to have him in my corner!
I always leave my appointment feeling very optimistic knowing I am receiving the best treatments possible and care from Dr Rose.
very positive experience
Dr. Rose address all my concerns in a professional manner. He is a definite asset to the organization. He is extremely knowledgeable about his field, kind and caring.
Dr. Rose is a remarkable physician and is a kind, compassionate man. He spends time understanding my condition and concerns and councils with me about treatment options and opportunities. I recommend him to any person with MS.
Fellow and physician talked about getting an xray on my knee, but there was no action or follow-up on this discussion.
I appreciate Dr. Rose and his kindness and patience in answering my questions
Dr Germaine and Dr Rose and exceptional providers. I couldn't have asked for a better visit.
The medical assistant gave me a choice if I wanted the students in with the doctor at which I declined them because I was tired I wanted to get home as soon as possible. Doctor rose came in 1st thing he said to me was I needed to find a new clinic because this is what they do in this clinic and I was like what are you talking about I had no idea and in that time I started crying when I realized it's because I declined the student nurses to come in
Patient and listened to me
Dr. Rose is the best.
Excellent
I've been seeing Dr. Rose for 25+ years and he is a excellent neurologist. The drawback I have is why does the office still continue to wear face mask.
Dr. Rose is always thorough and discusses my treatment and any concerns I may have.
Dr Rose is a terrific doctor. Have seen him for 20+ years
I love Dr. Rose and staff! They are amazing! I drive all the way from Utah valley and have since 2003.
As Always Dr Rose and his team are kind helpful and accommodating
Dr. Rose always takes time and listens and follows up He could see that I was tired at the end of the exam and asked if I would like a wheelchair to the lobby. Thank you!
As I said Dr. Rose is the best. I've seen many many doctors and he is 1 in a million. He's truly a wonderful doctor.
Visit went very well
Dr Rose was informative and asked great questions.
Good
I appreciate Dr. Rose so much!
There's always a lot to cover in my appts and it's my fault for not remembering to ask now questions about treatment options. I wish the physical assessment stuff didn't take up so much time of my appts. All the checking of sensations and vision and balance. I realize it's important but I feel like it would be better to listen to what I say about any changes I am experiencing and not be quite so focused on the tests.
I've been seeing Dr. Rose for 26 years and I'm pleased with his concerns about my MS in my L leg as it's weaker plus suggest I take a supplement that will help me with walking.
Very hood listener. He asks questions other MD fon't
Dr. Rose is wonderful and has been for 25+ years
Dr. Rose is one of the best physicians in the world! His advice and care is practical and invaluable.
We love Dr. Rose
Dr. Rose is very professional and one to whom I have recommended to others.
Dr. Rose knew exactly what was going on when he talked to me, examined me and discussed symptoms
Dr. Rose is the best!! He is so kind and knowledgeable.
Dr Rose is very attuned to his patient and their needs and concerns. He responds on the patients level of understanding so both parties comprehend.
Dr Rose Rocks! He's the best! A living legend.
I feel that sometimes it's not helpful to have the medical students in EVERY appt because it sometimes feels like they get so caught up in talking medical stuff to each other they forget to talk to me. The patient. The one who lives in the body and knows it better than anyone.
Didn't inform me of any risks from taking the new medication only benefits.
Dr Rose gave great information.
Dr. Rose is very good about treating you like any actual person.
Dr. Rose takes time to listen. he does not seem rushed.
I've recommended dr rose to a few of my MSer friends. I am so happy with the care he has given me these past 17? Years
very happy
I love Dr Rose!! He has been my provider for 12+ years. I trust him completely!!
I feel SOOOO lucky to have Dr. Rose, Julia Klein ( who I didn't see this time. ) Having one of the best in the country makes having this insidious disease a little more bearable.
hood
Was a good visit with Dr. Rose and his associates!
i love dr rose and dr poon and their colleague (i forgot her name unfortunately)
Dr. Rose is the best!
Dr. Rose is consistently attentive, and his the attending doctor was very personable and engaged. This is typical of my experience.
always love talking to Dr. Rosehe's the very best
Dr Rose is the best!
Explained everything as the visited proceeded.
all great
I was satisfied in every way with my appointment
I enjoy Dr Rose. He is very smart and actually takes his time to assess and explain. He is very patient and listens to your concerns.
My appointment was not at the clinic. it was done in Virtual Zoom. It wasn't as personable, but it was ok.
Both Dr. Rose and his Fellow (cant remember her name) were professional, caring and took time to explain things to me
Dr. Rose is always very thorough and so kind and helpful. His fellow was also great.